These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32039859)

  • 1. RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design.
    Finkel RS; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Shieh PB; Tizzano E; Desguerre I; Quijano-Roy S; Saito K; Droege M; Dabbous O; Khan F; Renault L; Anderson FA; Servais L
    J Neuromuscul Dis; 2020; 7(2):145-152. PubMed ID: 32039859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry.
    Servais L; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Proud CM; Shieh PB; Tizzano EF; Quijano-Roy S; Desguerre I; Saito K; Faulkner E; Benguerba KM; Raju D; LaMarca N; Sun R; Anderson FA; Finkel RS
    J Neuromuscul Dis; 2024; 11(2):425-442. PubMed ID: 38250783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study.
    Sahashi K; Hashizume A; Kuwatsuka Y; Chinen M; Saotome-Nakamura A; Ando M; Katsuno M
    JMIR Res Protoc; 2022 Dec; 11(12):e38878. PubMed ID: 36520510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Spinal Muscular Atrophy Registry for Real-World Evidence.
    Hodgkinson VL; Oskoui M; Lounsberry J; M'Dahoma S; Butler E; Campbell C; MacKenzie A; McMillan HJ; Simard L; Vajsar J; Brais B; Chapman KM; Chrestian N; Crone M; Dobrowolski P; Dojeiji S; Dowling JJ; Dupré N; Genge A; Gonorazky H; Hasal S; Izenberg A; Johnston W; Leung E; Lochmüller H; Mah JK; Marerro A; Massie R; McAdam L; McCormick A; Melanson M; Mezei MM; Nguyen CE; O'Connell C; O'Ferrall EK; Pfeffer G; Phan C; Plamondon S; Poulin C; Rodrigue X; Schellenberg KL; Selby K; Sheriko J; Shoesmith C; Smith G; Taillon M; Taylor S; Warman Chardon J; Worley S; Korngut L
    Can J Neurol Sci; 2020 Nov; 47(6):810-815. PubMed ID: 32493524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy.
    Pechmann A; König K; Bernert G; Schachtrup K; Schara U; Schorling D; Schwersenz I; Stein S; Tassoni A; Vogt S; Walter MC; Lochmüller H; Kirschner J
    Orphanet J Rare Dis; 2019 Jan; 14(1):18. PubMed ID: 30665421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.
    Cattinari MG; de Lemus M; Tizzano E
    Orphanet J Rare Dis; 2024 Feb; 19(1):76. PubMed ID: 38373977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
    Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Wenzel F; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Walter MC; Bertsche A; Vill K; Baumann M; Baumgartner M; Cordts I; Eisenkölbl A; Flotats-Bastardas M; Friese J; Günther R; Hahn A; Horber V; Husain RA; Illsinger S; Jahnel J; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schwerin-Nagel A; Reihle C; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Trollmann R; Weiler M; Weiß C; Wiegand G; Wilichowski E; Ziegler A; Lochmüller H; Kirschner J;
    Orphanet J Rare Dis; 2022 Oct; 17(1):384. PubMed ID: 36274155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The SMA France national registry: already encouraging results].
    Lemoine M; Gomez M; Grimaldi L; Urtizberea JA; Quijano-Roy S
    Med Sci (Paris); 2021 Nov; 37 Hors série n° 1():25-29. PubMed ID: 34878390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an academic disease registry for spinal muscular atrophy.
    Mercuri E; Finkel R; Scoto M; Hall S; Eaton S; Rashid A; Balashkina J; Coratti G; Pera MC; Samsuddin S; Civitello M; Muntoni F;
    Neuromuscul Disord; 2019 Oct; 29(10):794-799. PubMed ID: 31558335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany.
    Leibrock B; Landfeldt E; Hussong J; Huelle T; Mattheus H; Thiele S; Walter MC; Zemlin M; Moehler E; Dillman U; Abner S; Flotats-Bastardas M
    Orphanet J Rare Dis; 2023 Feb; 18(1):32. PubMed ID: 36810103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-source approach to determine SMA incidence and research ready population.
    Verhaart IEC; Robertson A; Leary R; McMacken G; König K; Kirschner J; Jones CC; Cook SF; Lochmüller H
    J Neurol; 2017 Jul; 264(7):1465-1473. PubMed ID: 28634652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
    Schwartz O; Vill K; Pfaffenlehner M; Behrens M; Weiß C; Johannsen J; Friese J; Hahn A; Ziegler A; Illsinger S; Smitka M; von Moers A; Kölbel H; Schreiber G; Kaiser N; Wilichowski E; Flotats-Bastardas M; Husain RA; Baumann M; Köhler C; Trollmann R; Schwerin-Nagel A; Eisenkölbl A; Schimmel M; Fleger M; Kauffmann B; Wiegand G; Baumgartner M; Rauscher C; Cirak S; Gläser D; Bernert G; Hagenacker T; Goldbach S; Probst-Schendzielorz K; Lochmüller H; Müller-Felber W; Schara-Schmidt U; Walter MC; Kirschner J; Pechmann A;
    JAMA Pediatr; 2024 Jun; 178(6):540-547. PubMed ID: 38587854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
    Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
    J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey.
    Belter L; Cruz R; Jarecki J
    Orphanet J Rare Dis; 2020 Aug; 15(1):217. PubMed ID: 32838797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review.
    Landfeldt E; Abner S; Pechmann A; Sejersen T; McMillan HJ; Lochmüller H; Kirschner J
    Pharmacoeconomics; 2023 Mar; 41(3):275-293. PubMed ID: 36515815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey.
    Toro W; Yang M; Georgieva M; Anderson A; LaMarca N; Patel A; Akbarnejad H; Dabbous O
    Adv Ther; 2023 Dec; 40(12):5315-5337. PubMed ID: 37776479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
    Papp KA; Gooderham M; Beecker J; Lynde CW; Delorme I; Dei-Cas I; Albrecht L; Rampakakis E; Sampalis JS; Vieira A; Hussein S; Chambenoit O; Rihakova L
    BMC Dermatol; 2019 Jun; 19(1):9. PubMed ID: 31226985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Difference in Spinal Muscular Atrophy Patients - are Males More Vulnerable?
    Sun J; Harrington MA; Porter B;
    J Neuromuscul Dis; 2023; 10(5):847-867. PubMed ID: 37393514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.